US pharmaceutical major Eli Lilly has announced a USD 1 billion investment in Telangana to expand its manufacturing and global medicine supply capabilities. The move underscores Hyderabad’s growing prominence as a hub for advanced pharmaceutical manufacturing and Global Capability Centers (GCCs)
Key Highlights
- Global Capability Centre (GCC): Eli Lilly inaugurated its GCC in Hyderabad in August 2025, providing a foundation for the company’s innovation and operational expansion in India
- Strategic Choice: Despite interest from multiple states, Telangana was chosen for its skilled workforce, strong infrastructure, and proactive government support
- High-Level Engagement: The announcement followed a meeting between Eli Lilly executives, Chief Minister . Revanth Reddy, and Industries Minister , Sridhar Babu at Hyderabad’s Integrated Command Control Centre
Investment Focus
The USD 1 billion expansion will focus on:
- Developing new medicines for diabetes, obesity, Alzheimer’s disease, cancer, and autoimmune conditions
- Manufacturing in Telangana with global supply capabilities, enabling export of medicines worldwide
Impact on Telangana
- Economic Growth: The investment is expected to strengthen Telangana’s industrial ecosystem and position Hyderabad as a global pharma and healthcare hub
- Job Creation: The expansion will generate employment opportunities across manufacturing, R&D, and support functions
- Innovation & Skill Development: Leveraging Telangana’s skilled talent pool, the investment will enhance capabilities in pharmaceutical innovation and biomanufacturing
Government Support
Industries Minister D. Sridhar Babu stated that Eli Lilly’s expansion reflects Telangana’s dynamic industrial landscape and growing global recognition in advanced healthcare manufacturing. The government has offered a supportive ecosystem, including policy incentives, infrastructure support, and ease of doing business
Conclusion
Eli Lilly’s USD 1 billion investment strengthens Telangana’s position as a preferred destination for global pharmaceutical companies and GCCs. Hyderabad is now poised to play a key role in global medicine development, manufacturing, and distribution, further enhancing India’s prominence in the international healthcare sector.
Visit Our News section and follow us on LinkedIn and Twitter
Read more full news: Here
